Roy Buchanan
Stock Analyst at JMP Securities
(5)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DVAX Dynavax Technologies | Reiterates: Market Outperform | 32 32 | 9.41 | 240.06% | 8 | Aug 22, 2025 | |
ENTA Enanta Pharma | Maintains: Market Outperform | 24 25 | 8.28 | 201.93% | 15 | Aug 12, 2025 | |
CDTX Cidara Therapeutics | Maintains: Market Outperform | 59 66 | 65.62 | 0.58% | 7 | Aug 8, 2025 | |
PYPD PolyPid | Maintains: Market Outperform | 16 14 | 3.47 | 303.46% | 2 | Jun 17, 2025 | |
CVAC CureVac | Reiterates: Market Outperform | 10 10 | 5.34 | 87.27% | 9 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 5 2 | 1.26 | 58.73% | 9 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 2.38 | 656.3% | 3 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 7 4 | 2.84 | 40.85% | 3 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 23 14 | 1.31 | 968.7% | 1 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 33 33 | 84.01 | -60.72% | 1 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 24 7 | n/a | n/a | 2 | Nov 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 4 5 | 4.46 | 12.11% | 5 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Jul 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 443 448 | 756.38 | -40.77% | 2 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 14 16 | 12.94 | 23.65% | 1 | Mar 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Feb 16, 2023 |